Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge

3 days ago 10

Jonathan Ponciano, The Motley Fool

Sun, December 7, 2025 astatine 8:50 AM CST 5 min read

New York City-based Newtyn Management accrued its involvement successful Indivior by astir 1.6 cardinal shares successful the 3rd quarter, resulting successful a nett presumption alteration of $62.8 million.
The transaction represents a astir 4.1% alteration successful 13F reportable assets nether management.
The money present holds 4.2 cardinal Indivior shares valued astatine $101.3 million, making it the fund's largest holding.
These 10 stocks could mint the adjacent question of millionaires ›

New York City-based Newtyn Management reported a bargain of astir 1.6 cardinal further Indivior PLC shares, expanding its presumption by an estimated $62.8 cardinal successful the 3rd quarter, according to a November 14 SEC filing.

According to a filing with the Securities and Exchange Commission dated November 14, Newtyn Management accrued its involvement successful Indivior PLC (NASDAQ:INDV) by astir 1.6 cardinal shares successful the 3rd quarter. The presumption worth roseate to $101.3 cardinal astatine quarter-end, reflecting some buying enactment and terms changes. Indivior present accounts for 12.4% of the firm’s U.S. equity assets, making it the apical holding successful a portfolio of 33 reported positions.

Top holdings aft the filing:

NASDAQ:INDV: $101.3 cardinal (12.4% of AUM)
NASDAQ:QDEL: $79.5 cardinal (9.7% of AUM)
NASDAQ:TBPH: $72.3 cardinal (8.8% of AUM)
NYSE:AD: $67.5 cardinal (8.3% of AUM)
NYSE:CNNE: $62.5 cardinal (7.6% of AUM)

As of Friday, shares of Indivior PLC were priced astatine $35.12, up a staggering 212% implicit the past twelvemonth and good outperforming the S&P 500, which is up 13% successful the aforesaid period.

Metric

Value

Price (as of marketplace adjacent Friday)	$35.12
Market Capitalization	$4.4 billion
Revenue (TTM)	$1.2 billion
Net Income (TTM)	$124 million

Indivior PLC develops and markets buprenorphine-based therapies for opioid usage disorder, including SUBLOCADE, SUBUTEX PRO, SUBOXONE, and SUBUTEX, arsenic good arsenic OPVEE nasal spray for opioid overdose and PERSERIS for schizophrenia.
The institution generates gross chiefly done the merchantability of proprietary medicine pharmaceuticals targeting substance usage and intelligence wellness disorders, leveraging a portfolio of some marketed and pipeline products.
Indivior serves healthcare providers, addiction attraction centers, and authorities agencies successful the United States, the United Kingdom, and planetary markets.

Indivior PLC is simply a specialty pharmaceutical institution focused connected addressing opioid dependence and related disorders done innovative therapies and a robust merchandise pipeline. The institution leverages its expertise successful addiction attraction to support a starring presumption successful the healthcare sector. Indivior's strategical investments successful probe and partnerships enactment its competitory borderline successful addressing unmet needs successful substance usage and intelligence wellness treatment.